M&A Deal Summary

ArchiMed and Omnes Capital Acquire NAMSA

On September 1, 2020, private equity firms ArchiMed and Omnes Capital acquired medical products company NAMSA

Acquisition Highlights
  • This is ArchiMed’s 6th and Omnes Capital’s 4th transaction in the Medical Products sector.
  • This is ArchiMed’s 4th and Omnes Capital’s 10th transaction in the United States.
  • This is ArchiMed’s 1st and Omnes Capital’s 1st transaction in Ohio.

M&A Deal Summary

Date 2020-09-01
Target NAMSA
Sector Medical Products
Buyer(s) ArchiMed
Omnes Capital
Deal Type Buyout (LBO, MBO, MBI)

Target

NAMSA

Northwood, Ohio, United States
website
NAMSA is a medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. NAMSA was established in 1967 and is based in Northwood, Ohio.

Search 193,924 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

DESCRIPTION

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €5 to €300 million per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.


DEAL STATS #
Overall 19 of 35
Sector (Medical Products) 6 of 9
Type (Buyout (LBO, MBO, MBI)) 12 of 19
State (Ohio) 1 of 1
Country (United States) 4 of 8
Year (2020) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-18 ActiGraph

Pensacola, Florida, United States

ActiGraph is a developer of wearable, remote monitoring technology for academic studies, and drug trials. ActiGraph’s mobility and sleep tracking hardware, software and analysis solutions are the most widely used research-grade monitoring systems for activity in the world. ActiGraph was founded in 2004 and is based in Pensacola, Florida.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-01 Prollenium

Richmond Hill, Ontario, Canada

Prollenium is a developer, manufacturer, and distributor of medical aesthetics products. The company’s product expertise and technical knowledge covers the field of facial aesthetics products, ingredients optimization and technical quality testing. Prollenium’s flagship product Revanesse is a line of cross-linked hyaluronic acid dermal fillers. Prollenium was founded in 2002 and is based in Richmond Hill, Ontario.

Buy -
Buyer

Omnes Capital

Paris, France

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 2004
PE ASSETS 5.7B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Omnes Capital formerly known as Credit Agricole Private Equity (CAPE) is the investment arm of financial services group Credit Agricole. Omnes Capital looks to invest in a range of investment stages and transaction types, including LBO/expansion, venture capital, mezzanine, renewable energy, co-investment, infrastructure, and special situations. The Firm's LBO/expansion group looks to invest €25 to €80 million to support growth initiatives and buyouts of small and mid-cap businesses operating in a variety of industries. Omnes Capital generally invests in businesses operating in France and Italy. Omnes Capital's mezzanine area was formed in 2002 and looks to provide €5 to €30 million of junior capital to similar sized established businesses. In addition to Omnes Capital's traditional equity and subordinated debt investment arm, the Firm also invests in infrastructure projects as well as provides capital for distressed businesses with €10 to €150 million in revenue. Omnes Capital was formed in 2004 and is based in Paris.


DEAL STATS #
Overall 155 of 162
Sector (Medical Products) 4 of 4
Type (Buyout (LBO, MBO, MBI)) 73 of 74
State (Ohio) 1 of 1
Country (United States) 10 of 10
Year (2020) 6 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-20 Biofutur

L'Isle-Adam, France

Biofutur is a group of medical biology analysis laboratories, managed by independent medical biologists. The Biofutur group wishes to continue its development thanks, among other things, to the quality of its local medical care and its patient service. Biofutur is based in L'Isle-Adam, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-07 Adents High-Tech International

Massy, France

Adents High-Tech International engages in design, development, and distribution of traceability solutions. Adents High-Tech International was founded in 2007 and is based in Massy, France.

Sell -